Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research Article

DISPOSITION AND ANTICONVULSANT ACTIVITY OF BROMAZEPAM IN MICE

MORTON A. SCHWARTZ, WILLIAM R. POOL, DOROTHY L. HANE and EDWARD POSTMA
Drug Metabolism and Disposition January 1974, 2 (1) 31-39;
MORTON A. SCHWARTZ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
WILLIAM R. POOL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOROTHY L. HANE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
EDWARD POSTMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

This article has a correction. Please see:

  • Disposition and Anticonvulsant Activity of Bromazepam in Mice - March 01, 1974

Abstract

The intravenous administration of 0.30 mg of bromazepam-2-14C per kg to mice resulted in a fairly uniform distribution of unchanged drug in plasma, brain, and muscle. While the drug was eliminated monoexponentially with a half-life of only 18 min, 3-hydroxybromazepam, the only metabolite detected in plasma, brain, and muscle, rose to peak levels at 1 hr and then was eliminated with an apparent half-life of 4.1 hr. The anticonvulsant activity of bromazepam given intravenously to mice 1 min to 6 hr before the intravenous injection of 70 mg (CD100) of pentylenetetrazol (Metrazol) per kg decreased from an ED50 of 0.27 mg/kg to an ED50 of 1.4 mg/kg. At 1 min, the activity was due solely to unchanged drug; at 1 hr and later, brain levels of intact drug were barely detectable or nonmeasurable, and the metabolite was apparently responsible for the anticonvulsant activity of bromazepam. From the brain levels which resulted from each bromazepam ED50, it was estimated that protection of 50% of the mice against the Metrazol CD100 was afforded by 0.22 µg of bromazepam per g or 0.18 µg of 3-hydroxybromazepam per g. Whereas bromazepam and 3-hydroxybromazepam had almost the same intrinsic activity, the activity of the metabolite given intravenously 1 min before Metrazol was only one-third that of bromazepam given similarly. This suggests that the uptake of 3-hydroxybromazepam by brain was less efficient than that of bromazepam. Finally, the rate of 3-hydroxybromazepam elimination obtained from the tissue level data was shown to approximate that obtained by pharmacokinetic evaluation of the anticonvulsant activity data.

Footnotes

    • Received August 2, 1973.
  • Copyright © 1974 by The American Society for Pharmacology and Experimental Therapeutics

 

DMD articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition
Vol. 2, Issue 1
1 Jan 1974
  • Table of Contents
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
DISPOSITION AND ANTICONVULSANT ACTIVITY OF BROMAZEPAM IN MICE
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research Article

DISPOSITION AND ANTICONVULSANT ACTIVITY OF BROMAZEPAM IN MICE

MORTON A. SCHWARTZ, WILLIAM R. POOL, DOROTHY L. HANE and EDWARD POSTMA
Drug Metabolism and Disposition January 1, 1974, 2 (1) 31-39;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research Article

DISPOSITION AND ANTICONVULSANT ACTIVITY OF BROMAZEPAM IN MICE

MORTON A. SCHWARTZ, WILLIAM R. POOL, DOROTHY L. HANE and EDWARD POSTMA
Drug Metabolism and Disposition January 1, 1974, 2 (1) 31-39;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics